Read More 21 minute read Options Stocks That Hit 52-Week Lows On Wednesday By Benzinga Insights September 28, 12:40 PM Wednesday's session saw 361 companies set new 52-week lows. AA
Read More 27 minute read Options Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights September 27, 12:42 PM On Tuesday, 456 stocks hit new 52-week lows. AAN
Read More 29 minute read Options Stocks That Hit 52-Week Lows On Friday By Benzinga Insights September 16, 2:08 PM During Friday's session, 574 stocks hit new 52-week lows. ACCO
Read More 21 minute read Options Stocks That Hit 52-Week Lows On Tuesday By Benzinga Insights September 6, 1:42 PM On Tuesday, 400 companies set new 52-week lows. AAN
Read More 28 minute read Options Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights September 1, 12:58 PM On Thursday, 529 companies set new 52-week lows. $APE
Read More 8 minute read Markets Movers News Penny Stocks Pre-Market Outlook Small Cap Trading Ideas This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday By Lisa Levin August 4, 5:54 AM Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. AAWW
Read More 3 minute read Intraday Update Markets Movers 12 Information Technology Stocks Moving In Wednesday’s Intraday Session By Benzinga Insights August 3, 2:09 PM AYX
Read More 5 minute read Intraday Update Markets Movers News Penny Stocks Small Cap Trading Ideas Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday’s Mid-Day Session By Lisa Levin August 3, 12:59 PM Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. AAWW
Read More 2 minute read Intraday Update Markets Movers News Penny Stocks Small Cap Trading Ideas AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday By Lisa Levin August 3, 11:33 AM Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results. AIZ
Read More 1 minute read Analyst Ratings Downgrades News Price Target Roth Capital Downgrades Knowles to Neutral, Lowers Price Target to $17 By Benzinga Newsdesk August 3, 5:55 AM Roth Capital analyst Suji Desilva downgrades Knowles (NYSE:KN) from Buy to Neutral and lowers the price target from $30 to $17. KN